Premenopausal Endocrine Responsive Chemotherapy Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edith A. Perez, MD
North American Intergroup, Mayo Clinic Jacksonville, Jacksonville, USA
Study Chair - Rosalba Torrisi, MD
Breast International Group, European Institute of Oncology, Milano, Italy
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Institute of Oncology
Budapest, Hungary
- Centro Di Riferimento Oncologico - Aviano
Aviano, Italy
- European Institute of Oncology
Milan, Italy
- Kantonsspital Graubuenden
Chur, Switzerland
- Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
- Kantonsspital - St. Gallen
Sankt Gallen, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2003
- Primary completion
- 31 Dec 2006
- Completion
- 31 Dec 2006
- Last update posted
- 28 Oct 2016
- Registered enrollment
- 29
- Registry id
- NCT00066807
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.